Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pulse Biosciences, Inc - Common Stock
(NQ:
PLSE
)
19.12
-0.91 (-4.54%)
Streaming Delayed Price
Updated: 3:03 PM EDT, May 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pulse Biosciences, Inc - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results
March 27, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For March 27, 2025
↗
March 27, 2025
Via
Benzinga
PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024
↗
August 22, 2024
Pulse Biosciences just reported results for the second quarter of 2024.
Via
InvestorPlace
Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
March 26, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
March 07, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 04, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
February 20, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
February 04, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting
January 30, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
January 21, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium
January 13, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
January 10, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 03, 2025
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
December 23, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
December 19, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
December 17, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
November 01, 2024
Via
Benzinga
Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association
October 31, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results
October 30, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology
October 30, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024
October 21, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
↗
August 13, 2024
Via
Benzinga
Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results
August 12, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors
August 12, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System
August 08, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
August 01, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024
July 29, 2024
From
Pulse Biosciences, Inc.
Via
Business Wire
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
↗
July 12, 2024
The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-than-expected June inflation data and potential interest rate cuts.
Via
Benzinga
Topics
Economy
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
July 08, 2024
Via
Benzinga
S&P 500, Nasdaq Extend Record Highs; Dow Up Triple Digits
↗
July 08, 2024
The Dow Jones Industrial Average is up triple digits midday, as investors look ahead to this week's inflation data.
Via
Talk Markets
Topics
Economy
Stocks
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
